LAUSR

Graphical abstract Figure. No Caption available. Abstract Epilepsy is one of the serious neurological sequelae of bacterial meningitis. Rifampicin, the well‐known broad spectrum antibiotic, is clinically used for chemoprophylaxis of meningitis. Besides its antibiotic effects, rifampicin has been proven to be an effective neuroprotective candidate in various experimental models of neurological diseases. In addition, rifampicin was found to have promising antioxidant, anti‐inflammatory and anti‐apoptotic effects. Herein, we investigated the anticonvulsant effect of rifampicin at experimental meningitis dose (20 mg/kg, i.p.) using lithium‐pilocarpine model of status epilepticus (SE) in rats. Additionally, we studied the effect of rifampicin on seizure induced histopathological, neurochemical and behavioral abnormalities. Our study showed that rifampicin pretreatment attenuated seizure activity and the resulting hippocampal insults marked by hematoxylin and eosin. Markers of oxidative stress, neuroinflammation and apoptosis were evaluated, in the hippocampus, 24 h after SE induction. We found that rifampicin pretreatment suppressed oxidative stress as indicated by normalized malondialdehyde and glutathione levels. Rifampicin pretreatment attenuated SE‐induced neuroinflammation and decreased the hippocampal expression of interleukin‐1&bgr;, tumor necrosis factor‐&agr;, nuclear factor kappa‐B, and cyclooxygenase‐2. Moreover, rifampicin mitigated SE‐induced neuronal apoptosis as indicated by fewer positive cytochrome c immunostained cells and lower caspase‐3 activity in the hippocampus. Furthermore, Morris water maze testing at 7 days after SE induction showed that rifampicin pretreatment can improve cognitive dysfunction. Therefore, rifampicin, currently used in the management of meningitis, has a potential additional advantage of ameliorating its epileptic sequelae.